European VC Outperforms the US Over 20 Years. So Why Does Conviction Feel So Hard?
On a 10–20 year horizon, European VC returns beat the US on both IRR and MOIC. The data is surprising — and it points to an opportunity most funds are leaving on the table.
Wouter Neyndorff
CEO

Start with the data most people get wrong. European VC 10-year net IRR: 20.77%. US VC 10-year net IRR: 18.18%. Over 20 years, European MOIC comes in at 2.4× against 2.11× for the US.
These are Cambridge Associates figures. They are not widely cited, because they contradict the conventional wisdom that European venture is structurally inferior to its American counterpart. They are also true.
So why, if European VC outperforms on a long-horizon basis, does building conviction feel so hard — and why are so many European investors still pricing deals without a real read on the technology they're backing?
Where the US does have an advantage
The long-run return picture is real, but it comes with caveats. US VC outperforms significantly on short-term rolling returns — in 2024, US VC funds returned +1.9% over trailing 12 months against –15.7% for European funds. LP payback speed: 4.5 years in the US versus 6.7 years in Europe.
The US also leads on capital scale. $209 billion invested in 2024 against Europe's $62.4 billion. In AI specifically, the gap is 10×. At the very top, the 10 largest US funds captured 33% of all capital raised; Europe's top 10 captured 17%.
And on deal speed, the divergence is structural: a US Series A closes in 6–12 weeks. A European Series A takes 4–6 months. A US term sheet in a hot deal is issued in 8 days or less. In Europe, weeks to months.
The conviction gap is the real story
European VCs must build confidence across a longer process with fewer real-time competitive signals. A Dutch Series A partner put it clearly in our research: 'By the time we've moved through our full process, we've already formed a view on price. The diligence that follows is largely confirmatory. If something materially changes, we're in an awkward negotiation with a founder we've already committed to emotionally.'
This is the conviction problem. European funds move slowly not because they're less decisive, but because the structure of their process — multi-jurisdictional legal complexity, formal IC cycles, absence of standardised term frameworks — makes it hard to build full conviction quickly.
The result: deals get confirmed, not discovered. The best returns come from being right about something early. European processes are optimised for thoroughness, not for early conviction.
The entry valuation advantage is real — but only if you can act on it
Here is the opportunity hiding in plain sight. US median seed valuations are more than 2× European equivalents. European B2B startups generate approximately 10% more value per invested capital than US counterparts when measured on enterprise value per euro deployed. US developer salaries are ~60% higher than European equivalents.
Europe has 5.7 million developers against 4.4 million in the US — more builders, at lower cost, building for a 450 million consumer market with fundamentally different regulatory and enterprise requirements than the US.
The fund that can move quickly on a European company with a compelling technical foundation, before the price reflects that reality, is the fund that captures the return advantage. The valuation entry advantage is real. But it only translates to outperformance if the fund can actually assess what they're backing — fast enough to act.
What closes the gap
Speed of conviction is the lever. Not speed of legal process — that's structural and unlikely to change. But speed of technical conviction: how quickly can a fund go from 'commercially interested' to 'we know what we're backing and we're prepared to pay for it'?
The funds closing this gap are building technical assessment into the front of their process, not the back. They're not running tech DD post-LOI as a confirmatory exercise. They're running it pre-LOI as a conviction-building tool — getting the same information faster, making the technical section of the IC memo credible, and moving to terms before competing funds have finished their first round of meetings.
Europe generates 17% of new global enterprise value. It captures only 10% of exit value. The gap between creation and capture is not inevitable. The funds that will close it are the ones that figure out how to move with American speed on European technical depth. That combination doesn't exist yet at scale. It's the opportunity.
For investors who want to move faster
X-Ray is the fastest way to get technical conviction on a European deal. 1 business day. 250+ checks. Operator-verified. Benchmarked against 250+ European assessments from Seed to Series C+. The fund that gets there first wins the deal.
Sources
- Cambridge Associates — 10-year net IRR: Europe 20.77% vs. US 18.18%; 20-year MOIC: Europe 2.4× vs. US 2.11×
- Atomico, State of European Tech 2025 — 10-year IRR 17.2% (Europe) vs. 13.1% (US); Q2 2025 rolling returns
- KPMG Venture Pulse Q4 2024 — .4B Europe vs. B US total VC invested 2024
- PitchBook — Deal timeline comparisons, fund concentration data
- Equidam — European vs. US dilution data, 23 quarters 2020–2025
- Harvard Business School Private Capital Project — European deal process quote
- Atomico — 17% global enterprise value created in Europe, 10% captured at exit
Services
Keep reading
Related articles

Why European VCs Are Pricing Deals Blind — And What It's Costing Them
50–60% of European early-stage deals proceed without any formal tech DD. New data shows what that's actually costing investors — and when in the process the damage is done.

The EU AI Act Creates a New Diligence Obligation. Most European VCs Aren't Ready.
36–39% of European deal flow in 2025 involves AI-first companies. The EU AI Act's high-risk provisions take full effect in August 2026. Here's what every European investor needs to assess — and what happens if they don't.

'The Technical Section of Our IC Memo Is Always the Weakest Part'
An anonymous associate at a Benelux VC told us something most deal teams won't say out loud. It points to a structural gap in how European funds assess technical risk — and who actually carries the cost.
Start with an X-Ray.
1 business day. The complete picture. 250+ assessments delivered.